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Detection of noncyling cows by heatmount decectors and ultrasound before
treatment with progesterone
Abstract
Our objective was to determine accuracy of identifying anovulatory lactating dairy cows before the
application of a timed AI protocol [with or without progesterone supplementation via a controlled internal
drug release (CIDR) insert and 2 different timings of AI] by using heatmount detectors and a single
ovarian ultrasound examination. At 6 Midwest locations, 1,072 cows were enrolled in a Presynch protocol
(2 injections of prostaglandin F2α(PGF2α) 14 days apart) with the second injection administered 14 days
before initiating the Ovsynch protocol (injection of gonadotropin releasing hormone (GnRH) 7 days before
and 48 hours after PGF2αinjection, with timed AI at 0 or 24 hours after the second GnRH injection).
Heatmount detectors were applied to cows at the time of the first Presynch injection, assessed 14 days
later at the second Presynch injection and again at initiation of the Ovsynch protocol, and ovaries were
examined for presence of a visible corpus luteum (CL) by ultrasound before initiation of treatment.
Treatments were assigned to cows based on presence or absence of a visible CL: 1) anovulatory (no CL +
CIDR insert for 7 d); 2) anovulatory (no CL + no CIDR); and 3) cycling (CL present). Further, every other
cow in the 3 treatments was assigned to be inseminated concurrent with the second GnRH injection of
Ovsynch (0 hour) or 24 hours later. Pregnancy was diagnosed at 33 and 61 days after the second GnRH
injection. Heatmount detectors and a single ultrasound examination both underestimated proportions of
cows classified as anovulatory or having no prior luteal activity compared with those classifications
determined by concentrations of progesterone in blood serum. Overall accuracy of heatmount detectors
and ultrasound was 71 and 84%, respectively. Application of progesterone to cows without a CL at the
time of the first injection of GnRH reduced incidence of ovulation but improved pregnancy rates at day 33
or 61 compared with nontreated cows without a CL at the onset of the Ovsynch protocol. Pregnancy rates
and pregnancy survival did not differ for cows having a CL before treatment compared with those not
having a CL but treated with progesterone. Pregnancy rates were 1.5-fold greater for cows ovulating in
response to the first GnRH injection. Timing of AI at 0 or 24 hours after the second GnRH injection did not
alter pregnancy rates, but cows having prior luteal activity before treatment had improved pregnancy rates
compared with anovulatory cows. We conclude that identifying anovulatory cows by ultrasound was more
accurate than by heatmount detectors. Subsequent treatment of potential anovulatory cows with
progesterone failed to improve fertility but had benefit for cows with prior estrous cycles at the onset of
the timed AI (TAI) protocol, regardless of luteal status before the final luteolytic injection of PGF2α.; Dairy
Day, 2007, Kansas State University, Manhattan, KS, 2007; Dairy Research, 2007 is known as Dairy Day,
2007
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DETECTION OF NONCYCLING COWS BY HEATMOUNT DETECTORS AND
ULTRASOUND BEFORE TREATMENT WITH PROGESTERONE
J. S. Stevenson, D. E. Tenhouse, R. L. Krisher,G. C. Lamb, C. R. Dahlen, J. E. Larson,
J. R. Pursley, N. M. Bello, P. M. Fricke, M. C. Wiltbank, D. J. Brusveen,
M. Burkhart, R. S. Youngquist, and H. A. Garverick1
Summary

be inseminated concurrent with the second
GnRH injection of Ovsynch (0 hour) or 24
hours later. Pregnancy was diagnosed at 33
and 61 days after the second GnRH injection.
Heatmount detectors and a single ultrasound
examination both underestimated proportions
of cows classified as anovulatory or having no
prior luteal activity compared with those classifications determined by concentrations of
progesterone in blood serum. Overall accuracy of heatmount detectors and ultrasound
was 71 and 84%, respectively. Application of
progesterone to cows without a CL at the time
of the first injection of GnRH reduced incidence of ovulation but improved pregnancy
rates at day 33 or 61 compared with nontreated cows without a CL at the onset of the
Ovsynch protocol. Pregnancy rates and pregnancy survival did not differ for cows having
a CL before treatment compared with those
not having a CL but treated with progesterone.
Pregnancy rates were 1.5-fold greater for cows
ovulating in response to the first GnRH injection. Timing of AI at 0 or 24 hours after the
second GnRH injection did not alter pregnancy rates, but cows having prior luteal activity before treatment had improved pregnancy rates compared with anovulatory cows.
We conclude that identifying anovulatory
cows by ultrasound was more accurate than by
heatmount detectors. Subsequent treatment of

Our objective was to determine accuracy
of identifying anovulatory lactating dairy
cows before the application of a timed AI protocol [with or without progesterone supplementation via a controlled internal drug release (CIDR) insert and 2 different timings of
AI] by using heatmount detectors and a single
ovarian ultrasound examination. At 6 Midwest
locations, 1,072 cows were enrolled in a Presynch protocol (2 injections of prostaglandin
F2α (PGF2α) 14 days apart) with the second
injection administered 14 days before initiating the Ovsynch protocol (injection of gonadotropin releasing hormone (GnRH) 7 days before and 48 hours after PGF2α injection, with
timed AI at 0 or 24 hours after the second
GnRH injection). Heatmount detectors were
applied to cows at the time of the first Presynch injection, assessed 14 days later at the
second Presynch injection and again at initiation of the Ovsynch protocol, and ovaries
were examined for presence of a visible corpus luteum (CL) by ultrasound before initiation of treatment. Treatments were assigned to
cows based on presence or absence of a visible CL: 1) anovulatory (no CL + CIDR insert
for 7 d); 2) anovulatory (no CL + no CIDR);
and 3) cycling (CL present). Further, every
other cow in the 3 treatments was assigned to
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at 16 hours after the second GnRH injection.
In practice, this timing is somewhat inconvenient and does not correspond to other management activities (e.g., AI, pregnancy diagnosis, vaccinations, and other treatments) that
often occur while dairy cows are locked up at
the feed line after morning milkings. Further,
AI-pregnancy rates were not too different
when AI occurred concurrent with the second
GnRH injection or 24 hours later.

potential anovulatory cows with progesterone
failed to improve fertility but had benefit for
cows with prior estrous cycles at the onset of
the timed AI (TAI) protocol, regardless of
luteal status before the final luteolytic injection of PGF2α.
(Key words: anovulation, controlled internal
drug release, Ovsynch, pregnancy rates.)
Introduction

The objectives of the present experiment
were to determine: 1) accuracy of detecting
anovulatory cows (no prior estrous cycles) by
using heatmount detectors applied to cows
during the 28 days before initiating the
Ovsynch protocol or by a single ovarian examination employing transrectal ultrasonography at the onset of the Ovsynch protocol; 2)
benefit of applying progesterone (via a CIDR
insert) during the first 7 days of the Ovsynch
protocol; and 3) pregnancy rates after timing
of AI occurred concurrent with the second
GnRH injection of the Ovsynch protocol or 24
hours later.

Because fertility of lactating dairy cows is
poor and has decreased more than 50% since
1970, improving fertility of lactating dairy
cows is economically important to dairy producers. A previous study examined effects of
supplemental progesterone via a progesteronereleasing, intravaginal CIDR insert in various
experimental designs. Conception rates were
greater for cows treated with progesterone
during the Ovsynch protocol (injection of
GnRH 7 days before and 48 hours after PGF2α
injection, with TAI between 0 and 24 hours
after the second GnRH injection) at 28 and 56
days after TAI, respectively. In that study,
conception rates were more positive for both
cycling and noncycling or anovulatory cows
treated with the CIDR insert compared with
no CIDR treatment but only at 4 of the 6 locations at 28 days and at 3 of 6 locations at 56
days after TAI. This inconsistent response is
corroborated by other large-scale studies.

Procedures
Experimental Locations
This study was a collaborative project of
the North Central Regional Research Project
1006 of the Cooperative States Research,
Education, and Extension Service (CSREES).
Similar treatments were applied to lactating
Holstein cows at 6 locations (Indiana, Kansas,
Michigan, Minnesota, Missouri, and Wisconsin) where co-authors were located. A total of
1,072 cows were enrolled between April 2003
and October 2005. A similar experimental design was used at each location. New cows
were enrolled weekly or biweekly into breeding clusters.

Estrus-detection aids including tail paint,
chalk, and heatmount detectors are inexpensive tools that may aid in the detection of noncycling cows before first AI. Likewise, examination of ovaries by transrectal palpation
or ultrasonography is a means of identifying
anovulatory cows that may benefit from progesterone supplementation as part of a TAI
protocol.
Pregnancy rates are maximized when the
TAI of the Ovsynch protocol is administered

13

Experimental Protocol
Sampling, procedures, and design of
treatments are illustrated (Figure 1). Cows
were enrolled in a Presynch + Ovsynch protocol. Two, 25-mg injections of PGF2α (5 mL
of Lutalyse, Pfizer, New York, NY or 5 mL of
Prostamate, Phoenix Scientific, Inc., St. Joseph, MO) were given i.m. 14 days apart, and
the Ovsynch protocol was initiated 14 days
after the second Presynch injection with the
first injection of GnRH. Prostaglandin F2α (25
mg) was administered 7 days later and followed in 48 hours by a second injection of
GnRH. All injections of GnRH (100 μg) were
administered i.m., consisting of 2 mL of OvaCyst (Phoenix Scientific, Inc.).

Treatments were assigned to cows based on
presence of a visible CL (CL absent vs. CL
present): 1) anovulatory (no CL + CIDR insert
for 7 d); 2) anovulatory (no CL + no CIDR);
and 3) cycling (CL present). Further, every
other cow within the 3 treatments was assigned to be inseminated concurrent with the
second GnRH injection of Ovsynch (0 hour)
or 24 hours later. Pregnancy was diagnosed at
33 and 61 days after the second GnRH injection. Presence of fluid in the uterus, a CL, and
a viable embryo were evidence of pregnancy.
For cows that were pregnant at the first diagnosis (day 33), a subsequent ultrasound examination at day 61 was used to determine
pregnancy loss.

Heatmount detectors (Kamar Inc., Steamboat Springs, CO) were affixed midline to the
rump of each cow between the tail head and
the tuber coxae (hook bones). Detectors were
placed on all cows before the first Presynch
injection and were assessed before the second
Presynch and the first GnRH injection of
Ovsynch. Condition of heatmount detector
was recorded as red, absent, white, or partially
red (leaky). A new detector was applied before each injection if the detector was activated or absent. For purposes of this experiment, sexual behavior associated with estrus
was assumed to have occurred when the heatmount detector was activated or absent (ovulatory or cycling cows). Leaky or nonactivated
detectors were assumed to be associated with
no prior estrual activity (anovulatory or noncycling cows).

At 3 locations (KS, MI, and MI), follicles
also were mapped and sized at further ovarian
exams performed by ultrasound before the
PGF2α and second GnRH injections of
Ovsynch and at 5 days after the second GnRH
injection to determine if ovulation occurred in
response to the second GnRH injection. Blood
was collected at all locations before each hormonal injection and again at 5 and 12 days
after the second GnRH injection. Concentrations of progesterone were measured to determine prior luteal activity before and after
treatments.
Results and Discussion
Location Characteristics
Various outcomes of lactating dairy cows
treated at each of 6 locations are summarized
in Table 1. A total of 1,072 cows were enrolled in the study in 6 Midwest states. Nearly
all traits in Table 1 differed among locations,
except for pregnancy rate at day 33. Calving
difficulty scores averaged 1.3 ± 0.48 (SD) and
ranged from 1.2 to 1.7. Average body condition score after calving and before the first
Presynch injection (37 ± 7 DIM) were 2.8 ±
0.48 (SD) and 2.6 ± 0.44 (SD), respectively.

Treatments
At the onset of the Ovsynch protocol, ovaries were examined by using transrectal ultrasonography. Ultrasonography was conducted
by using a transrectal 5.0 or 7.5 MHz lineararray transducer (Aloka 500V; Corometrics
Medical Systems, Inc., Wallingford, CT). Follicles and luteal structures were mapped, and
follicles were sized by using internal calipers.
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Days in milk (DIM) at TAI averaged 75 ±
7 (SD), with all cows first inseminated between 61 and 107 days (90% were inseminated between 61 and 82 DIM). Pregnancy
rates at days 33 and 61 averaged in the low to
mid 30% range, with pregnancy loss averaging 10.2%. Cows having prior luteal activity
before treatment (65 ± 7 DIM), as assessed by
concentrations of progesterone in 3 blood
samples collected during 28 days before treatment, averaged 83.7%. Regression of the CL
in response to the PGF2α of the Ovsynch protocol averaged 88.5% across locations.

Ovarian Characteristics in Response to Progesterone
Our second objective was to determine the
effects of progesterone (CIDR insert) in cows
identified with or without a CL at the onset of
the Ovsynch protocol. This assessment was
made by a single ultrasound examination of
ovaries at all 6 locations, and as cited earlier,
some cows were not correctly categorized by
the single examination. Incidence of ovulation
in response to the first GnRH injection was
less (P < 0.05) in cows having no CL and
treated with progesterone (CIDR insert) than
in no CL cows not receiving a CIDR (Table
2). Average incidence of ovulation was less
(P < 0.001) for cows having a CL than for
those without a CL (Table 2). Concentrations
of progesterone for cows in the 3 previous
classifications at onset of treatment were 0.7 ±
0.2, 0.6 ± 0.2, and 4.0 ± 0.1 ng/mL, respectively.

Detection of Anovulatory Cows
Our first objective was to determine the
accuracy of detecting anovulatory cows by
means of heatmount detectors or a single ultrasound examination of ovarian structures in
comparison with blood serum concentrations
of progesterone. Both assessments were made
at all 6 locations. Overall, relative to 3 blood
serum concentrations assessed during 28 days
before treatment, heatmount detectors and a
single ultrasound exam of ovarian structures
underestimated both anovulation and previous
luteal or cycling activity. Relative to serum
progesterone patterns, however, overall accuracy of heatmount detectors was 71.4% and
that of a single ultrasound examination was
84%. Ultrasound differed (P < 0.001) from
heatmount detectors in every category except
for apparent prevalence, including being more
(P < 0.001) sensitive and specific than heatmount detectors, with the Kappa coefficient
(0.52) in the good-agreement range compared
with detectors (0.11). Heatmount detectors
had greater (P < 0.001) rates of false positives
(identifying incorrectly prior estrual activity
and subsequent luteal activity) and false negatives (missing prior estrual activity and subsequent luteal activity).

Diameter of the ovulatory follicle, assessed before the second GnRH injection, was
smaller (P < 0.001) in cows with a CL present
than for those with no CL, regardless of CIDR
treatment (Table 2). Incidence of ovulation of
that follicle, assessed 5 days later (after TAI),
did not differ among cows having or not having a CL (Table 2) at the onset of treatment.
Fertility in Response to Progesterone
Pregnancy rates at days 33 and 61 and
pregnancy loss in 1,068 cows (4 were culled
before pregnancy diagnosis) during that interval are summarized in Table 2 for all 6 locations. Cows having a CL present at initiation
of treatment had greater (P < 0.05) pregnancy
rates at days 33 and 61 than those not having a
CL . However, pregnancy rate at day 33 in CL
absent cows treated with a CIDR did not differ
from that in cows having a CL before treatment but was greater than for CL absent cows
not treated with a CIDR. Cows requiring no
calving assistance (calving difficulty score
[CDS] = 1) subsequently had greater
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tions of progesterone before the before injection of PGF2α injection of Ovsynch is examined further in Table 4. Because of the inaccuracy of identifying cycling status by ultrasound relative to blood concentrations of progesterone in these cows, 55.5% of 155 CL absent cows were truly not cycling and treated
with a CIDR. Further, 44% of 116 CL absent
cows were truly not cycling and assigned to
the no CIDR treatment. These 2 groups of
cows are designated by their pretreatment cycling status in Table 4

(P < 0.05) pregnancy rates than those requiring some (CDS > 1) assistance (42.7%; n =
693 vs. 34.3%; n = 375), respectively.
Pregnancy rates at day 61 followed the
same pattern as those at day 33 (Table 2).
Overall pregnancy loss was 10.4% and tended
(P < 0.10) to be less in cows having a CL at
the onset of treatment compared with cows not
having a CL (Table 2).
Time of Insemination
Our third objective was to determine
whether time of AI relative to the second
GnRH injection (0 vs. 24 hours) altered pregnancy rates (Table 3). The largest difference
(5.4 percentage points in 24 hours) in pregnancy rate at day 33 for timing of AI was observed in CL present cows. Otherwise, time of
AI had no little effect on pregnancy outcome
measured at day 33. Cows having a CL present at treatment initiation had greater (P <
0.05) pregnancy rates than CL absent cows
not treated with a CIDR when inseminated at
24 hours, but not 0 hours after the second
GnRH injection.

Effects of treatment of anovulatory cows
based on serum concentrations of progesterone are summarized in the top 3 lines of Table
4, and treatment effects on previously cycling
cows are summarized in the bottom 3 lines of
Table 4. When only previously anovulatory
cows were treated or not treated with a CIDR,
their pregnancy rates did not differ from those
in CL present cows regardless of progesterone
concentrations at the time of the PGF2α injection (Table 4). In contrast, regardless of progesterone concentrations at the time of the
PGF2α injection, CL absent cows treated with
a CIDR and CL cows had greater pregnancy
rates than the CL absent cows not treated with
a CIDR (Table 4). Overall, cows having prior
cycling activity, assessed by blood progesterone before treatment, had 53% greater (P <
0.001) pregnancy rates at day 33 than those
without prior luteal activity (37.8 vs. 24.7%;
Table 4).

A CIDR treatment × location interaction
tended (P = 0.085) to occur (Table 3) for
pregnancy rates at day 33. Pregnancy rates for
cows treated with a CIDR insert were greater
at 4 locations than non-CIDR treated cows,
but were less than non-CIDR treated cows at
the other 2 locations. An interaction of location × time of AI tended (P = 0.12) to occur,
in which pregnancy rates for cows inseminated at 0 hour were numerically greater at 3
locations, but lesser at 3 other locations. Overall, pregnancy rates at 24 hours were numerically greater than those made at 0 hour
(37.4%, n = 530 vs. 34%, n = 538), respectively.

Treatment with the CIDR insert in a previous study improved pregnancy rates in cows
that were previously noncycling without a
functional CL before the PGF2α injection, but
not in the present study (Table 4). Further,
CIDR treatment in previously cycling cows
having low concentrations of progesterone
before PGF2α injection (early CL regression)
had numerically greater pregnancy rates in the
present study as in a previous study. Interpretation of the results in the previous study indi-

Concentrations of Progesterone
The relationship of pretreatment cycling
status and presence of high vs. low concentra-
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later is consistent with an earlier report in
which cows treated with CIDR inserts during
the Ovsynch protocol had greater progesterone
concentrations than controls. It seems that maturing follicles exposed to progesterone during
CIDR treatment may, after ovulation, differentiate into CL having greater progesterone
secretory capacity.

cated that the CIDR insert would improve
conception rates in cows having no active CL
or low progesterone before PGF2α injection
regardless of previously cycling or luteal
status, whereas in the present study, we could
only verify improved fertility for previously
cycling cows having low progesterone (early
CL regression). Although interpretation of results in the present study relative to luteal
status before PGF2α injection should be conservative because luteal status was confounded with CIDR-supplemented progesterone concentrations, nearly 26% of the CL absent cows treated with a CIDR had concentrations of progesterone < 1 ng/mL when the insert was removed. Clearly, these cows had no
CL at this time. Concentrations of progesterone in cows bearing a luteal structure are generally not different before and after the insert
is removed.

As expected, pregnancy status had no effect on concentrations of progesterone at 5
days after the second GnRH injection, but at
12 days, pregnant cows had greater (P <
0.001) concentrations of progesterone than
nonpregnant cows (4.7 ± 0.2; n = 686 vs. 3.6 ±
0.1 ng/mL; n = 381).
In summary, identifying cows with a CL
was more accurate after the single ultrasound
examination than during the 28 days when
heatmount detectors were applied to cows.
When lactating dairy cows were found to have
no CL (but had evidence of increased concentrations of progesterone in blood serum during
28 days before initiating the Ovsynch protocol) at the onset of the Ovsynch protocol and
treated with progesterone (via a CIDR), pregnancy rates were greater than similar CL absent cows not treated with a CIDR. Pregnancy
rates of the former did not differ from cows
having a CL at the initiation of the TAI protocol. Our study finds no evidence that including progesterone in a TAI protocol for previously noncycling cows is warranted, regardless of luteal status before the PGF2α injection
of the Ovsynch protocol. Insemination of
cows at 0 vs. 24 hours after the second GnRH
injection did not differ significantly, even
though a numerical advantage (5.4 percentage
points) occurred for CL present cows inseminated at 24 vs. 0 hours.

Concentrations of progesterone in blood
serum 2 days before the second GnRH injection (day of PGF2α injection of Ovsynch and
removal of CIDR inserts), before the second
GnRH injection, and 5 and 12 days later are
illustrated in Figure 2. At insert removal,
cows treated with CIDR inserts had concentrations of progesterone that did not differ from
those in cows without inserts, but both treatments had less (P < 0.05) progesterone than in
CL present cows. This same pattern existed
48 hours later when the second GnRH injection was given (0 h). At 5 days after AI, no
differences in progesterone concentration
were detected among treatments, but at 12
days after the second GnRH injection or 11 to
12 days after AI, CL absent cows, regardless
of CIDR treatment, had greater (P < 0.05)
concentrations of progesterone than CL present cows. The greater progesterone 12 days
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Table 1. Selected Outcomes of Lactating Dairy Cows Enrolled at Each Location
Location
Item
IN
KS
MI
MN MO
WI
Total
Cows enrolled, no.
80
217
153
194
242
186 1,072
1
a
a,b
c
d
a
Calving difficulty score
1.5
1.3
1.2
1.7
1.4
1.3b,c 1.3**
Body condition score post-calving1
2.9a
2.6b 2.7c
3.1d 2.9a
… 2.8**
1,2
a
b
c
d
…
2.3
2.4
2.8
2.7
2.9c 2.6**
Body condition score at Presynch
Days postpartum at first AI3
72a
79b
82c
69d
75e
72a
75**
4
Pregnancy rate at 33 d , %
37.5
42.9 36.0
29.4 33.1
36.3
35.7
4
a
a
a
b
a,b
a
Pregnancy rate at 61 d , %
37.5
37.3 33.3
22.7 29.8
35.2
32.0*
a,c
b
a,c
b
c
c
Pregnancy loss (33 to 61 d), %
0.0
12.9 7.3
22.8 10.0
3.0
10.2*
5
a
a
a
b
c
a,c
92.5
91.2 89.5
69.1 79.3
87.3
83.7**
Luteal activity before treament , %
6
a,b
b,c
b
b
a
a,c
Regression of CL , %
88.4
86.7
87.4
81.9 94.8
90.6
88.5**
**Location effect (P < 0.01).
*Location effect (P < 0.05).
a,b,c,d,e
Location values having different superscript letters differ (P ≤ 0.05).
1
Range of 1 to 5. Standard deviations ranged from 0.44 to 0.48.
2
Assessed before first Presynch PGF2α injection.
3
Standard deviation was 7.0.
4
Determined by transrectal ultrasonography after the first postpartum AI.
5
Based on progesterone concentrations measured in a total of 3 blood samples collected before each Presynch PGF2α injection and before ultrasonography at the time of the first GnRH injection of the Ovsynch protocol. Cutoff values for luteal activity were based on progesterone ≥ 1
ng/mL and < 1 ng/mL for no luteal activity.
6
Cows having elevated concentrations of progesterone 48 to 72 hours before AI in which
blood progesterone was < 1 ng/mL at 48 hours after the PGF2α injection of the Ovsynch protocol.
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Table 2. Ovarian Characteristics and Fertility in Response to Presence or Absence of a
Corpus Luteum (CL) Assessed by Transrectal Ultrasonography and Progesterone Treatment (CIDR insert) at the Onset of the Ovsynch Protocol
Item

CL absent1
No CIDR
CIDR

CL present1

Ovulation after first GnRH2, % (no.)

76.8a (69)

47.1b (104)

43.4c,x (604)

Presence of CL before PGF2α2, % (no.)

76.8a (69)

51.0b (104)

95.7c,x (610)

0.9a ± 0.1 (55)4

0.7a ± 0.1(78)

1.4b ± 0.1 (450)

16.7a ± 0.4
(65)4

16.2a ± 0.4
(103)

15.2b,x ± 0.1
(588)

77.9 (68)

75.0 (104)

80.7 (605)

Pregnancy rate at day 33, % (no.)

24.1a (116)

32.3b (155)

38.0b,x (797)

Pregnancy rate at day 61, % (no.)

20.7a (116)

29.0b (155)

34.3b,x (797)

Corpus luteum before PGF2α3
Diameter of ovulatory follicle before second GnRH2, mm
Ovulation after second GnRH2, % (no.)

Pregnancy loss from day 33 to 61, % (no.)
14.3 (28)
10.0 (50)
9.9y (303)
a,b,c
Means having different superscript letters differ (P ≤ 0.05).
x
Different (P ≤ 0.05) from CL absent cows.
y
Tended (P ≤ 0.10) to differ from CL absent cows.
1
Absence or presence of a CL assessed by transrectal ultrasonography at the first GnRH injection of the Ovsynch protocol.
2
Assessed at only 3 of 6 locations.
3
Assessed at only 2 of 6 locations.
4
Mean ± SE and number of observations.
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Table 3. Pregnancy Rates at Day 33 After Timed Insemination on the Basis of Time of AI
After the Second GnRH Injection and Location
CL absent1
CL present1
Item
No CIDR
CIDR
Overall
AI time, hour after second GnRH
-------------------- % (no.) -------------------a
0
24.1 (54) 33.8a (74)
35.4a (401)
34.0 (530)
24
24.2a (62) 30.9a (81)
40.8b,x (395)
37.4 (538)
2
Location
IN
22.2 (9)
18.8 (16)
45.5 (55)
37.5 (80)
KS
21.7 (23)
26.1 (23)
48.0 (171)
42.9 (217)
MI
12.5 (16)
58.3 (12)
36.8 (125)
35.9 (153)
MN
21.6 (37)
32.4 (34)
30.9 (123)
29.4 (194)
MO
35.0 (20)
29.0 (62)
34.4 (160)
33.1 (242)
WI
36.4 (11)
62.5 (8)
35.2 (162)
36.3 (182)
a,b
Means within AI timing having different superscript letters differ (P ≤ 0.05).
x
Different (P ≤ 0.05) from corpus luteum (CL) absent cows at 24 hours.
1
Absence or presence of a CL assessed by transrectal ultrasonography at the first GnRH injection of the Ovsynch protocol.
2
Interaction (P = 0.08) of treatment × location.

Table 4. Pregnancy Rates at Day 33 After Timed Insemination According to Luteal
Activity Before Treatment and Concentrations of Progesterone at the Time of PGF2α
Injection
Serum
progesterone
CL absent3
Pretreatment
Pretreatment
before
1
2
3
cycling total
cycling status
PGF2α
CL present
No CIDR
CIDR
Noncycling

High
Low
Total

----------------------------- % (no.) ----------------------------29.4 (34)
32.1 (56)
32.0a,b (25)
17.6 (17)
6.7 (30)
16.7a,x (12)
25.4a (51)
23.3a (86)
27.0a (37)
24.7 (174)

High
25.9 (54)
44.1 (59)
40.2b (651)
Low
9.1 (11)
40.0 (10)
28.7a,b (108)
a
b
Total
23.1 (65)
42.8b(759)
43.5 (69)
37.8* (893)
a,b
Treatment × cycling status interaction (P = 0.08).
*Differed (P < 0.05) from noncycling cows.
1
Based on progesterone concentrations measured in 3 blood serum samples collected before
each Presynch PGF2α injection and before the first GnRH injection of the Ovsynch protocol.
2
Low = concentrations of progesterone < 1 ng/mL, and high = ≥ 1 ng/mL.
3
Absence or presence of a corpus luteum (CL) assessed by transrectal ultrasonography at the
first GnRH injection of the Ovsynch protocol. Some CIDR-treated cows may have had elevated
progesterone because of the CIDR insert.
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Figure 1. Experimental Protocol Showing Design of Treatments. Heatmount detectors (K)
were applied to detect mounted activity. Activated heatmount detectors were replaced at each
evaluation. Blood (B) was collected before various injections and twice post AI. Presence of a
corpus luteum (CL) was detected by transrectal ultrasonography (US) and, alternatively, cows
without a CL received a progesterone-releasing intravaginal controlled internal drug release
(CIDR) insert. Cows having a CL present received no CIDR. All cows received GnRH at 48
hours after PGF2α (PGF) and were inseminated before the second GnRH injection (0 hour) or 24
hours later in the 3 treatments. Pregnancy was diagnosed at 33 days after timed AI and reconfirmed at 61 days after timed AI.
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Figure 2. Concentrations of Progesterone in Serum of Lactating Dairy Cows Before Injections of PGF2α [time of progesterone (CIDR) Insert Removal; day −2] and the Second
GnRH Injection (day 0), and at 5 and 12 Days After GnRH. a,b Means having different superscript letters differ (P < 0.05).
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